Barbara Parker, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer (NCT02776917) | Barbara Parker, MD | 2018-08-15 |
Track Barbara Parker, MD automatically
Every clearance here is in the API, with alerts when new ones post.